Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Stem Cells Translational Medicine

Topics

Medicine

Immunology

Pathology

Internal Medicine

Surgery

Show all topics

DOI

10.1002/sctm.20-0472

License

CC-BY-NC-ND

Other Formats

PDF